Skip to main content
SpringerLink
Log in

Miscellaneous Neoplasms

  • Chapter
  • First Online:
The ASCRS Textbook of Colon and Rectal Surgery

Abstract

While adenomas and adenocarcinoma account for the ­majority of colorectal neoplasms, several other less frequent types of malignancy can occur, which can often present as diagnostic and therapeutic challenges to the clinician. These tumors can be classified based on their tissue of origin and include epithelial, mesenchymal, neural, vascular, or lymphoid tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kulke MH, Mayer RJ. Carcinoid tumours. N Engl J Med. 1999;340:858–68.

    CAS  PubMed  Google Scholar 

  2. Ganim RB, Norton JA. Recent advances in carcinoid pathogenesis, diagnosis and management. Surg Oncol. 2000;9:173–9.

    CAS  PubMed  Google Scholar 

  3. Eriksson B, Oberg K, Stridsberg M. Tumour markers in neuroendocrine tumours. Digestion. 2000;62:33–8.

    CAS  PubMed  Google Scholar 

  4. Lucas KJ, Feldman JM. Flushing in the carcinoid syndrome and plasma kallikrein. Cancer. 1986;58:2290–3.

    CAS  PubMed  Google Scholar 

  5. Reubi JC, Laissue J, Waser B. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci. 1994;733:122–37.

    CAS  PubMed  Google Scholar 

  6. Rea F, Binda R, Spreafico G. Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg. 1989;47:412–4.

    CAS  PubMed  Google Scholar 

  7. Schreurs AJ, Westermann CJ, van den Bosch JM. A twenty-five-year follow-up of ninety-three resected typical carcinoid tumours of the lung. J Thorac Cardiovasc Surg. 1992;104:1470–5.

    CAS  PubMed  Google Scholar 

  8. Barclay TH, Schapira DV. Malignant tumours of the small intestine. Cancer. 1983;51:878–81.

    CAS  PubMed  Google Scholar 

  9. Makridis C, Oberg K, Juhlin C. Surgical treatment of mid-gut carcinoid tumors. World J Surg. 1990;14:377–83.

    CAS  PubMed  Google Scholar 

  10. Moertel CG, Dockerty MB, Judd ES. Carcinoid tumors of the vermiform appendix. Cancer. 1968;21:270–8.

    CAS  PubMed  Google Scholar 

  11. Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 1987;317:1699–701.

    CAS  PubMed  Google Scholar 

  12. Berardi RS. Carcinoid tumors of the colon (exclusive of the rectum): review of the literature. Dis Colon Rectum. 1972;15:383–91.

    CAS  PubMed  Google Scholar 

  13. Jetmore AB, Ray JE, Gathright Jr JB. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum. 1992;35:717–25.

    CAS  PubMed  Google Scholar 

  14. Naunheim KS, Zeitels J, Kaplan EL. Rectal carcinoid tumors – treatment and prognosis. Surgery. 1983;94:670–6.

    CAS  PubMed  Google Scholar 

  15. Burke M, Shepherd N, Mann CV. Carcinoid tumours of the rectum and anus. Br J Surg. 1987;74:358–61.

    CAS  PubMed  Google Scholar 

  16. Eriksson B, Oberg K. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook. Ann Oncol. 1999;10:S31–8.

    PubMed  Google Scholar 

  17. Kubota A, Yamada Y, Kagimoto S. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in the treatment of human endocrine tumors. J Clin Invest. 1994;93:1321–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Kvols LK, Moertel CG, O’Connell MJ. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med. 1986;315:663–6.

    CAS  PubMed  Google Scholar 

  19. Tomassetti P, Migliori M, Corinaldesi R, Gullo L. Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR. Aliment Pharmacol Ther. 2000;14:557–60.

    CAS  PubMed  Google Scholar 

  20. O’Toole D, Ducreux M, Bommelaer G, Wemeau JL, Bouché O, Catus F, et al. Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer. 2000;88:770–6.

    PubMed  Google Scholar 

  21. Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, et al. Octreotide acetate long-acting formulation ­versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol. 1999;17:600–6.

    CAS  PubMed  Google Scholar 

  22. Moertel CG, Hanley JA. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin Trials. 1979;2(4):327–34.

    CAS  PubMed  Google Scholar 

  23. Engstrom PF, Lavin PT, Moertel CG, Folsch E, Douglass Jr HO. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol. 1984;2(11):1255–9.

    CAS  PubMed  Google Scholar 

  24. Bukowski RM, Johnson KG, Peterson RF, Stephens RL, Rivkin SE, Neilan B, et al. A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study. Cancer. 1987;60(12):2891–5.

    CAS  PubMed  Google Scholar 

  25. Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68(2):227–32.

    CAS  PubMed  Google Scholar 

  26. Moertel CG, Johnson CM, McKusick MA, Martin Jr JK, Nagorney DM, Kvols LK, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med. 1994;120(4):302–9.

    CAS  PubMed  Google Scholar 

  27. Schupak KD, Wallner KE. The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors. Int J Radiat Oncol Biol Phys. 1991;20(3):489–95.

    CAS  PubMed  Google Scholar 

  28. Virgolini I, Britton K, Buscombe J, Moncayo R, Paganelli G, Riva P. In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial. Semin Nucl Med. 2002;32(2):148–55.

    PubMed  Google Scholar 

  29. Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumours. Endocr Relat Cancer. 2004;11(1):1–18.

    CAS  PubMed  Google Scholar 

  30. Rengtgen DS, Thompson W, Garbutt J, Seigler HF. Radiologic, endoscopic and surgical considerations of melanoma metastatic to the GI tract. Surgery. 1984;95:635–9.

    Google Scholar 

  31. Malik A, Hull TL, Floruta C. What is the best surgical treatment for anorectal melanoma? Int J Colorectal Dis. 2004;19(2):121–3.

    PubMed  Google Scholar 

  32. Tessier DJ, McConnell EJ, Young-Fadok T, Wolff BG. Melanoma metastatic to the colon: case series and review of the literature with outcome analysis. Dis Colon Rectum. 2003;46(4):441–7.

    PubMed  Google Scholar 

  33. Ollila DW, Essner R, Wanek LA, Morton DL. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg. 1996;131:975–9.

    CAS  PubMed  Google Scholar 

  34. Allen PJ, Cott DG. The surgical management of metastatic melanoma. Ann Surg Oncol. 2002;9(8):762–70.

    PubMed  Google Scholar 

  35. Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol. 2000;12:181–5.

    CAS  PubMed  Google Scholar 

  36. Kawashima A, Fishman EK, Kuhlman JE, Schuchter LM. CT of malignant melanoma: patterns of small bowel and mesenteric involvement. J Comput Assist Tomogr. 1991;15:570–1.

    CAS  PubMed  Google Scholar 

  37. Damian DL, Fulham MJ, Thompson E, Thompson JF. Positron emission tomography in the detection and management of metastatic melanoma. Melanoma Res. 1996;6:325–9.

    CAS  PubMed  Google Scholar 

  38. Buzaid AC, Sandler AB, Mani S, Curtis AM, Poo WJ, Bolognia JL, et al. Role of computed tomography in the staging of primary melanoma. J Clin Oncol. 1993;11:638–43.

    CAS  PubMed  Google Scholar 

  39. Agrawal S, Yao TJ, Coit DG. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol. 1999;6:636–44.

    Google Scholar 

  40. Khadra MH, Thompson JF, Milton GW, McCarthy WH. The justification for surgical treatment of metastatic melanoma of the gastrointestinal tract. Surg Gynecol Obstet. 1990;171:413–6.

    CAS  PubMed  Google Scholar 

  41. Ricaniadis N, Konstandoulakis MM, Walsh D, Karakousis CP. Gastrointestinal metastases from malignant melanoma. Surg Oncol. 1995;4:105–10.

    CAS  PubMed  Google Scholar 

  42. Clemmensen OJ, Fenger C. Melanoctyes in the anal canal ­epithelium. Histopathology. 1991;18:237–41.

    CAS  PubMed  Google Scholar 

  43. Avital S, Romaguera RL, Sands L, Marchetti F, Hellinger MD. Primary malignant melanoma of the right colon. Am Surg. 2004;70:649–51.

    PubMed  Google Scholar 

  44. Sarah P, MaNiff JF, Madison MD, Wen-Jen Poo H, Bayar S, Sallem RR. Colonic melanoma, primary or regressed primary. J Clinic Gastroenterol. 2000;30:440–4.

    Google Scholar 

  45. Gervasoni Jr JE, Wanebo HJ. Cancers of the anal canal and anal margin. Cancer Invest. 2003;21(3):452–64.

    PubMed  Google Scholar 

  46. Blecker D, Abraham S, Furth EE, Kochman ML. Melanoma of the gastrointestinal tract. Am J Gastroenterol. 1999;94(12):3427–33.

    CAS  PubMed  Google Scholar 

  47. Wanebo HJ, Woodruff JM, Farr GH, Quan SH. Anorectal melanomas. Cancer. 1981;47:1891–5.

    CAS  PubMed  Google Scholar 

  48. Brady MS, Kavolius JP, Quan SH. Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer ­Center. Dis Colon Rectum. 1995;38(2):146–51.

    CAS  PubMed  Google Scholar 

  49. Billingsley KG, Stern LE, Lowy AM, Kahlenberg MS, Thomas Jr CR. Uncommon anal neoplasms. Surg Oncol Clin N Am. 2004;13(2):375–88.

    PubMed  Google Scholar 

  50. Yeh JJ, Shia J, Hwu WJ, Busam KJ, Paty PB, Guillem JG, et al. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 2006;244(6):1012–7.

    PubMed  PubMed Central  Google Scholar 

  51. Belli F, Gallino GF, Lo Vullo S, Mariani L, Poiasina E, Leo E. Melanoma of the anorectal region. The experience of the National Cancer Institute of Milano. Eur J Surg Oncol. 2009;35(7):757–62.

    CAS  PubMed  Google Scholar 

  52. Lens MB, Dawes M. Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials. J Clin Oncol. 2002;20(7):1818–25.

    CAS  PubMed  Google Scholar 

  53. Verma S, Quirt I, McCready D, Bak K, Charette M, Iscoe N. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer. 2006;106(7):1431–42.

    CAS  PubMed  Google Scholar 

  54. Kawano N, Tashiro M, Taguchi M, Kihara Y, Yoshikawa I, Syukuwa K, et al. Combined treatment with dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta in a patient with advanced anorectal malignant melanoma. Nippon Shokakibyo Gakkai Zasshi. 2008;105(11):1627–33.

    PubMed  Google Scholar 

  55. Quintas-Cardama A, Lazar AJ, Woodman SE, Kim K, Ross M, Hwu P, et al. Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib. Nat Clin Pract Oncol. 2008;5(12):737–40.

    CAS  PubMed  Google Scholar 

  56. Mazur MT, Clark HB. Gastric Stromal tumors: reappraisal of histogenesis. Am J Surg Pathol. 1983;7:507–19.

    CAS  PubMed  Google Scholar 

  57. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain of function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–80.

    CAS  PubMed  Google Scholar 

  58. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708–10.

    CAS  PubMed  Google Scholar 

  59. Biasco G, Velo D, Angriman I, Astorino M, Baldan A, Baseggio M, et al. Gastrointestinal stromal tumors: report of an audit and review of the literature. Eur J Cancer Prev. 2009;18(2):106–16.

    PubMed  Google Scholar 

  60. Steigen SE, Eide TJ. Gastrointestinal stromal tumors (GISTs): a review. APMIS. 2009;117:73–86.

    PubMed  Google Scholar 

  61. Tryggvason G, Gisalason HG, Magnusson MK, Jonasson JG. Gastrointestinal stromal tumors in Iceland, 1990–2003: the Icelandic GIST study, a population based incidence and pathologic risk stratification study. Int J Cancer. 2005;117:289–93.

    CAS  PubMed  Google Scholar 

  62. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long term follow up and review of the literature. Am J Surg Pathol. 2005;29:1373–81.

    PubMed  Google Scholar 

  63. Kingham TP, DeMatteo RP. Multidisciplinary treatment of gastrointestinal stromal tumors. Surg Clin N Am. 2009;89:217–33.

    PubMed  Google Scholar 

  64. Diment J, Tamborini E, Casali P, Gronchi A, Carney JA, Colecchia M. Carney triad: case report and molecular analysis of gastric tumor. Hum Pathol. 2005;36:112–6.

    CAS  PubMed  Google Scholar 

  65. Matyakhina L, Bei TA, McWhinney SR, Pasini B, Cameron S, Gunawan B, et al. Genetics of Carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab. 2007;92:3728–32.

    PubMed  Google Scholar 

  66. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30(1):90–6.

    PubMed  Google Scholar 

  67. Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen’s disease). Am J Surg Pathol. 2005;29(6):755–63.

    PubMed  Google Scholar 

  68. Agaimy A, Wünsch PH, Hofstaedter F, Blaszyk H, Rümmele P, Gaumann A, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol. 2007;31(1):113–20.

    PubMed  Google Scholar 

  69. Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era – a population-based study in western Sweden. Cancer. 2005;103(4):821–9.

    PubMed  Google Scholar 

  70. Ueyama T, Guo KJ, Hashimoto H, Daimaru Y, Enjoji M. A clinicopathologic and immunohistochemical study of gastrointestinal stromal tumors. Cancer. 1992;69:947–55.

    CAS  PubMed  Google Scholar 

  71. Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD. Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol. 2005;15(7):1407–14.

    PubMed  Google Scholar 

  72. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466–78.

    CAS  PubMed  Google Scholar 

  73. Goerres GW, Stupp R, Barghouth G, Hany TF, Pestalozzi B, Dizendorf E, et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate. Eur J Nucl Med Mol Imaging. 2005;32(2):153–62.

    CAS  PubMed  Google Scholar 

  74. Rader AE, Avery A, Wait CL, McGreevey LS, Faigel D, ­Heinrich MC. Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c-kit. Cancer. 2001;93:269–75.

    CAS  PubMed  Google Scholar 

  75. Stelow EB, Stanley MW, Mallery S, Lai R, Linzie BM, Bardales RH. Endoscopic ultrasound guided fine needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol. 2003;119:703–8.

    PubMed  Google Scholar 

  76. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg. 2006;243:738–45.

    PubMed  PubMed Central  Google Scholar 

  78. Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol. 2004;11:465–75.

    PubMed  Google Scholar 

  79. Yeh C, Chen H, Tang R, Tasi W, Lin P, Wang J. Surgical outcome after surgical resection of rectal leiomyosarcoma. Dis Colon Rectum. 2000;43:1517–21.

    CAS  PubMed  Google Scholar 

  80. van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet. 2001;358(9291):1421–3.

    PubMed  Google Scholar 

  81. Gold JS, DeMatteo RP. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg. 2006;244:176–84.

    PubMed  PubMed Central  Google Scholar 

  82. dos Santos Fernandes G, Blanke CD, Freitas D, Guedes R, Hoff PM. Perioperative treatment of gastrointestinal stromal tumors. Oncology. 2009;23(1):54–61.

    Google Scholar 

  83. Malhotra P, Singh M, Kochhar R, Nada R, Wig JD, Varma N, et al. Leukemia infiltration of bowel in chronic lymphocytic leukemia. Gastrointest Endosc. 2005;62(4):614–5.

    PubMed  Google Scholar 

  84. Heiberg E, Wolverson M, Sandaram M, Sheilds JB. CT findings in leukemia. AJR Am J Roentgenol. 1984;143:1317–23.

    CAS  PubMed  Google Scholar 

  85. Salek J, Sideridis K, White S. Chronic lymphocytic leukemia of the intestinal tract. Gastrointest Endosc. 2006;63(7):1072–3.

    PubMed  Google Scholar 

  86. Hunter T, Bjelland JC. Gastrointestinal complications of leukemia and its treatment. AJR Am J Roentgenol. 1984;142:513–8.

    CAS  PubMed  Google Scholar 

  87. Gavan DR, Hendry GM. Colonic complications of acute lymphoblastic leukemia. Br J Radiol. 1994;67:449–52.

    CAS  PubMed  Google Scholar 

  88. Sloas MM, Flynn PM, Kaste SC, Patrick CC. Typhlitis in children with cancer: a 30 year experience. Clin Infect Dis. 1993;17:484–90.

    CAS  PubMed  Google Scholar 

  89. Hayes Jr D, Leonardo JM. Neutropenic enterocolitis in a woman treated with 5-fluorouracil and leucovorin for colon carcinoma. NC Med J. 2002;63:132–4.

    Google Scholar 

  90. Avigan D, Richardson P, Elias A, Demetri G, Shapiro M, Schnipper L, et al. Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: a case series with a review of the literature. Cancer. 1998;83(3):409–14.

    CAS  PubMed  Google Scholar 

  91. Pestalozzi BC, Sotos GA, Choyke PL, Fisherman JS, Cowan KH, O’Shaughnessy JA. Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer. Cancer. 1993;71(5):1797–800.

    CAS  PubMed  Google Scholar 

  92. Paulino AF, Kenney R, Forman EN, Medeiros LJ. Typhlitis in a patient with acute lymphoblastic leukemia prior to the administration of chemotherapy. Am J Pediatr Hematol Oncol. 1994;16:348–51.

    CAS  PubMed  Google Scholar 

  93. Cunningham SC, Fakhry K, Bass BL, Napolitano LM. Neutropenic enterocolitis in adults: case series and review of the literature. Dig Dis Sci. 2005;50:215–20.

    PubMed  Google Scholar 

  94. Kulaylat M, Doerr R, Ambrus J. A case presentation and review of neutropenic enterocolitis. J Med. 1997;28:1–19.

    CAS  PubMed  Google Scholar 

  95. Hsu TF, Huang HH, Yen DH. ED presentation of neutropenic enterocolitis in adult patients with acute leukemia. Am J Emerg Med. 2004;22:276–9.

    PubMed  Google Scholar 

  96. Ullery BW, Pieracci FM, Rodney JRM, Barie PS. Neutropenic enterocolitis. Surg Infect. 2009;10(3):307–14.

    Google Scholar 

  97. Davila ML. Neutropenic enterocolitis. Curr Opin Gastroenterol. 2006;22:44–7.

    PubMed  Google Scholar 

  98. Gorshluter M, Ulrich M, Strehl J, Ziske C, Schepke M, Schmidt-Wolf IGH, et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Hematol. 2005;75:1–13.

    Google Scholar 

  99. Picardi M, Camera A, Pane F, Rotoli B. Improved management of neutropenic enterocolitis using early ultrasound scan and vigorous medical treatment. Clin Infect Dis. 2007;45:403–7.

    PubMed  Google Scholar 

  100. Villar HV, Warneke JA, Peck MD, Durie B, Bjelland JC, Hunter TB. Role of surgical treatment in the management of complications of the gastrointestinal tract in patients with leukemia. Surg Gynecol Obstet. 1987;165(3):217–22.

    CAS  PubMed  Google Scholar 

  101. Glenn J, Funkhouser WK, Schneider PS. Acute illnesses necessitating urgent abdominal surgery in neutropenic cancer patients: description of 14 cases and review of the literature. Surgery. 1989;105:778–9.

    CAS  PubMed  Google Scholar 

  102. Quayle FJ, Lowney JK. Colorectal lymphoma. Clin Colon Rectal Surg. 2006;19:49–53.

    PubMed  PubMed Central  Google Scholar 

  103. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, ­Hiddemann W, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19(18):3861–73.

    CAS  PubMed  Google Scholar 

  104. Zighelboim J, Larson MV. Primary colonic lymphoma, clinical presentation, histopathologic features and outcome with combination chemotherapy. J Clin Gastroenterol. 1994;18:291–7.

    CAS  PubMed  Google Scholar 

  105. Dionigi G, Annoni M, Rovera F, Boni L, Villa F, Castano P, et al. Primary colorectal lymphomas: review of the literature. Surg Oncol. 2007;16 Suppl 1:S169–71.

    PubMed  Google Scholar 

  106. Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the gastrointestinal tract. Br J Surg. 1961;49:80–9.

    CAS  PubMed  Google Scholar 

  107. Musallam K, Hatoum H, Barada K, Taher A, Salem ME, Malek EM, et al. Primary colorectal lymphoma. Med Oncol. 2010;27(2):249–54.

    PubMed  Google Scholar 

  108. Wong MTC, Eu KW. Primary colorectal lymphomas. Colorectal Dis. 2006;8:586–91.

    CAS  PubMed  Google Scholar 

  109. Lewin KJ, Ranchod M, Dorfmann RF. Lymphomas of the gastrointestinal tract – a study of 119 cases presenting with gastrointestinal disease. Cancer. 1978;43:693–707.

    Google Scholar 

  110. Contreary K, Nance FC, Becker WF. Primary lymphoma of the gastrointestinal tract. Ann Surg. 1980;191:593–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  111. Wychulis AR, Bears OH, Woolner LB. Malignant lymphoma of the colon – a study of 69 cases. Arch Surg. 1966;93:215–25.

    CAS  PubMed  Google Scholar 

  112. Fan CW, Changchien CR, Wang JY, Chen JS, Hsu KC, Tang R, et al. Primary colorectal lymphoma. Dis Colon Rectum. 2000;43(9):1277–82.

    CAS  PubMed  Google Scholar 

  113. Azab MB, Henry-Amar M, Rougier P, Bognel C, Theodore C, Carde P, et al. Prognostic factors in primary gastrointestinal non-Hodgkin’s lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer. 1989;64(6):1208–17.

    CAS  PubMed  Google Scholar 

  114. Jinnai D, Iwasa Z, Watanuki T. Malignant lymphoma of the large intestine – operative results in Japan. Surg Today. 1983;13:331–6.

    CAS  Google Scholar 

Download references

Acknowledgments.

This chapter was authored by ­Richard Devine and Marc Brand in the previous edition of this ­textbook.

Author information

Authors and Affiliations

  1. General Surgery Research, Site Lead, Colorectal Cancer Program Champlain LHIN, Investigator, Ottawa Regional Cancer Center, Affiliate Investigator, Ottawa Hospital Research Institute, Department of Surgery, The Ottawa Hospital – General Campus, Ottawa, ON, Canada

    Robin P. Boushey BSc, MD, PhD, CIP, FRCSC

  2. Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada

    Husein Moloo MD, MSc, FRCSC

  3. Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada

    Husein Moloo MD, MSc, FRCSC

Authors
  1. Robin P. Boushey BSc, MD, PhD, CIP, FRCSC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Husein Moloo MD, MSc, FRCSC
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Colon and Rectal Surgery, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA

    David E. Beck MD, FACS, FASCRS

  2. Department of Colorectal Surgery, Lahey Clinic, Tufts University School of Medicine, Burlington, Massachusetts, USA

    Patricia L. Roberts MD, FACS, FASCRS

  3. Section of Colon and Rectal Surgery, Rush Medical Center, Chicago, Illinois, USA

    Theodore J. Saclarides MD, FACS, FASCRS

  4. Department of Surgery, Spectrum Health, Grand Rapids, Michigan, USA

    Anthony J. Senagore MD, FACS, FASCRS

  5. Department of Surgery, UCI Medical Center, Orange, California, USA

    Michael J. Stamos MD, FACS, FASCRS

  6. Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, Florida, USA

    Steven D. Wexner MD, FACS, FASCRS, FRCS, FRCS(Ed)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 ASCRS (American Society of Colon and Rectal Surgeons)

About this chapter

Cite this chapter

Boushey, R.P., Moloo, H. (2011). Miscellaneous Neoplasms. In: Beck, D.E., Roberts, P.L., Saclarides, T.J., Senagore, A.J., Stamos, M.J., Wexner, S.D. (eds) The ASCRS Textbook of Colon and Rectal Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1584-9_49

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1584-9_49

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1581-8

  • Online ISBN: 978-1-4419-1584-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation